Tomorrow Investor

Food & Health
resized_image-98
Coca-Cola Explores Sale of Costa Coffee Six Years After $5 Billion Acquisition
Dateline: LONDON, August 24, 2025 – Coca-Cola Co (KO.N) is exploring a potential sale of Costa Coffee six years after acquiring the British chain for $5 billion1. The move signals a strategic shift as the beverage giant reassesses its diversification beyond traditional soft drinks amid changing consumer...
resized_image-77
Brazil Consumer Coffee Prices Drop 1% in July, Breaking 18-Month Rally
Dateline: RIO DE JANEIRO, August 12, 2025 – Brazilian consumer coffee prices fell 1.01% in July, marking...
resized_image-78
Apollo Hospitals Beats Q1 Profit Estimates on Strong Healthcare Demand
Dateline: MUMBAI, August 13, 2024 – India’s Apollo Hospitals Enterprise (APOLLOHOSP.BO) reported...
resized_image-8
Tyson Foods Raises Revenue Forecast as Strong Chicken Sales Drive Growth
Dateline: SPRINGDALE, August 4, 2024 – Tyson Foods (TSN) raised its annual revenue forecast Monday, sending...
resized_image-7
Unilever Beats Q2 Sales Expectations as Shares Jump 3% on Pricing Power
Dateline: LONDON, July 31, 2024 – Unilever (UL) posted 3.8% second-quarter underlying sales growth, beating...
resized_image-182
Kraft Heinz Beats Q2 Estimates as Sauce Sales Drive Home-Cooking Trend
Dateline: CHICAGO, July 30, 2025 – Kraft Heinz (KHC) beat second-quarter earnings estimates on Wednesday,...
resized_image-136
Food and Medicine Programs Drive Health Sector Investment Interest as Chronic Disease Prevention Focus Grows
Dateline: WASHINGTON, December 16, 2024 – Healthcare investors are increasingly targeting food-as-medicine...

Trending

fileName-eu-clears-doordash-s-3-9-billion-deliveroo-takeover-1757446199936
EU Clears DoorDash's 3.9 Billion Deliveroo Takeover
fileName-oracle-earnings-are-coming-soon-here-s-what-matters-most-to-wall-street-1757346634652
Key Points for Wall Street Ahead of Oracle Earnings Release
fileName-biontech-bristol-myers-immunotherapy-shows-encouraging-tumour-shrinkage-in-phase-ii-trial-1757346260973
BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial

CATEGORIES

SIGNUP TO OUR NEWSLETTER

Subscribe

Get breaking market insights directly to your inbox